Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Health Catalyst (HCAT) Total Non-Current Liabilities (2018 - 2025)

Health Catalyst (HCAT) has disclosed Total Non-Current Liabilities for 8 consecutive years, with $255.2 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Total Non-Current Liabilities fell 43.87% year-over-year to $255.2 million, compared with a TTM value of $255.2 million through Sep 2025, down 43.87%, and an annual FY2024 reading of $493.7 million, up 47.46% over the prior year.
  • Total Non-Current Liabilities was $255.2 million for Q3 2025 at Health Catalyst, down from $266.5 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $514.3 million in Q1 2025 and bottomed at $255.2 million in Q3 2025.
  • Average Total Non-Current Liabilities over 5 years is $342.6 million, with a median of $334.6 million recorded in 2024.
  • The sharpest move saw Total Non-Current Liabilities surged 181.93% in 2021, then plummeted 43.87% in 2025.
  • Year by year, Total Non-Current Liabilities stood at $295.3 million in 2021, then grew by 10.8% to $327.2 million in 2022, then grew by 2.34% to $334.8 million in 2023, then surged by 47.46% to $493.7 million in 2024, then crashed by 48.32% to $255.2 million in 2025.
  • Business Quant data shows Total Non-Current Liabilities for HCAT at $255.2 million in Q3 2025, $266.5 million in Q2 2025, and $514.3 million in Q1 2025.